BioCurex Announces New OncoPet Sample Collection Kit Ready to Ship to Distributors and Veterinarians
September 26, 2011 09:25 ET
|
BioCurex, Inc.
RICHMOND, British Columbia, Sept. 26, 2011 (GLOBE NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) today announced that the company's wholly owned subsidiary, OncoPet Diagnostics, Inc., has developed a way to...
BioCurex's RECAF(TM) Blood Test for Cancer Can Prevent Two Thirds of Unnecessary Prostate Biopsies
September 08, 2011 09:30 ET
|
BioCurex, Inc.
RICHMOND, British Columbia, Sept. 8, 2011 (GLOBE NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) today announced results indicating that its RECAF blood test for cancer can prevent 70% of unnecessary prostate...
BioCurex Presents Latest Advances on Its Proprietary Peptide RECAF(TM) Test in International Cancer Congress
August 25, 2011 09:35 ET
|
BioCurex, Inc.
RICHMOND, British Columbia, Aug. 25, 2011 (GLOBE NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) -- today announced that the Review Board for the 39th Annual Meeting of the International Society for Oncology...
BioCurex, Inc. Strengthens Management Team and Board of Directors
July 20, 2011 09:30 ET
|
BioCurex, Inc.
RICHMOND, British Columbia, July 20, 2011 (GLOBE NEWSWIRE) -- BioCurex, Inc. (OTCBB:BOCX) announced today that Paul D. Slowey, Ph.D. has joined the company as President with responsibilities in...
BioCurex Updates Its Shareholders
June 27, 2011 09:30 ET
|
BioCurex, Inc.
RICHMOND, British Columbia, June 27, 2011 (GLOBE NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX), a biotechnology company that is developing products based on patented and proprietary technology in the area...
International Peer Reviewed Scientific Journal Publishes BioCurex Article Showing That a Combination of its Cancer Marker RECAF and CA125 Can be Used for Ovarian Cancer Screening
June 08, 2011 08:30 ET
|
BioCurex, Inc.
RICHMOND, British Columbia, June 8, 2011 (GLOBE NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) today announced the publication of the article entitled: "Combination of CA125 and RECAF biomarkers for early...
BioCurex Contracts CaroLink Science Solutions to Pursue Strategy for 510(k) Filing
June 02, 2011 08:30 ET
|
BioCurex, Inc.
RICHMOND, British Columbia, June 2, 2011 (GLOBE NEWSWIRE) -- BioCurex, Inc. (OTCBB:BOCX) announced today that it has contracted the services of CaroLink Science Solutions to help expedite the FDA...
BioCurex Subsidiary Continues Marketing Expansion of its RECAF(TM) Test in Asia
May 13, 2011 09:25 ET
|
BioCurex, Inc.
RICHMOND, British Columbia, May 13, 2011 (GLOBE NEWSWIRE) -- BioCurex, Inc. (OTCBB:BOCX) announced today that its wholly owned subsidiary, OncoPet Diagnostics, has entered into a distribution...
BioCurex Subsidiary OncoPet Diagnostics Signs Distribution Agreement With Success Vision Biotek Inc. for RECAF(TM) Test for Companion Animals
May 03, 2011 09:30 ET
|
BioCurex, Inc.
RICHMOND, British Columbia, May 3, 2011 (GLOBE NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) announced today that its wholly owned subsidiary, OncoPet Diagnostics, has entered into a distribution agreement...
![Leukemia cell coated with RECAF](http://www.globenewswire.com/en/Attachment/LogoDisplay/219849?filename=219849.jpg&size=2)
Photo Release -- BioCurex Updates Its Shareholders on Technical and Business Advances
April 14, 2011 09:30 ET
|
BioCurex, Inc.
RICHMOND, British Columbia, April 14, 2011 (GLOBE NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) provides the following update to its shareholders on technological and business advances with its...